Citescorey = Citationsy + Citationsy-1 + Citationsy-2 + Citations y-3 / Published articlesy + Published articlesy-1 + Published articlesy-2 + Published articles y-3
Hernandez-Morales, Ilane, and Marnix Van Loock. "An industry perspective on dengue drug discovery and development." Dengue and Zika: Control and Antiviral Treatment Strategies (2018): 333-353. View at Publisher|View at Google Scholar|View at Indexing
Pujar, Gurubasavaraj V., et al. "Dengue Structural Proteins as Antiviral Drug Targets: Current Status in the Drug Discovery & Development." European Journal of Medicinal Chemistry (2021): 113527. View at Publisher|View at Google Scholar|View at Indexing
Blake K, Holbrook JT, Antal H, Shade D, Bunnell HT, McCahan SM, Wise RA, Pennington C, Garfinkel P, Wysocki T. Use of mobile devices and the internet for multimedia informed consent delivery and data entry in a pediatric asthma trial: Study design and rationale. Contemporary clinical trials. 2015 May 1;42:105-18. View at Publisher|View at Google Scholar|View at Indexing
Hutchinson, Nora, et al. "Patient Participation in Clinical Trials of Oncology Drugs and Biologics Preceding Approval by the US Food and Drug Administration." JAMA network open 4.5 (2021): e2110456-e2110456. View at Publisher|View at Google Scholar|View at Indexing
Anderle, Pascale, and Uyen Huynh-Do. "Educating Scientists in Translational and Entrepreneurial Medicine: Unmet Needs and Challenges." Technology Transfer and Entrepreneurship 4.2 (2017): 126-131. View at Publisher|View at Google Scholar|View at Indexing
Anguzu R, Akun PR, Ogwang R, Shour AR, Sekibira R, Ningwa A, Nakamya P, Abbo C, Mwaka AD, Opar B, Idro R. Setting up a clinical trial for a novel disease: a case study of the Doxycycline for the Treatment of Nodding Syndrome Trialâchallenges, enablers and lessons learned. Global health action. 2018 Jan 1;11(1):1431362. View at Publisher|View at Google Scholar|View at Indexing
Kron F, Bernschein A, Kostenko A, Wolf J, Hallek M, Glossmann JP. Cancer care: new value chains challenge german hospital structures—a comprehensive cancer center perspective. InBoundaryless Hospital 2016 (pp. 21-40). Springer, Berlin, Heidelberg. View at Publisher|View at Google Scholar|View at Indexing
Speich B, Gloy V, Schur N, Ewald H, Hemkens LG, Schwenkglenks M, Briel M, Group MR. A scoping review shows that several nonvalidated budget planning tools for randomized trials are available. Journal of clinical epidemiology. 2020 Jan 1;117:9-19. View at Publisher|View at Google Scholar|View at Indexing
Kron F, Kostenko A, Scheffler M, Müller D, Glossmann JP, Fischer R, Michels S, Nogova L, Hallek M, Zander T, Wolf J. Economic burden of clinical trials in lung cancer in a German Comprehensive Cancer Center. Lung Cancer. 2017 Jun 1;108:134-9. View at Publisher|View at Google Scholar|View at Indexing
Lea SC, Watts KL, Davis NA, Panayiotou B, Bankart MJ, Arora A, Chambers R. The potential clinical benefits of medicines optimisation through comprehensive geriatric assessment, carried out by secondary care geriatricians, in a general practice care setting in North Staffordshire, UK: a feasibility study. BMJ open. 2017 Sep 1;7(9):e015278. View at Publisher|View at Google Scholar|View at Indexing
Holmes E, Crome P, Arora A. Patientsâ preferences and existential perspective: what to consider and how should patientâs expectations be guided?. Aging clinical and experimental research. 2018 Mar;30(3):271-5. View at Publisher|View at Google Scholar|View at Indexing
Rodrigo R, Gormaz JG, Libuy M, Hasson D. Designing, Planning, and Conducting Clinical Trials. A Guide to the Scientific Career: Virtues, Communication, Research and Academic Writing. 2019 Nov 26:267-80. View at Publisher|View at Google Scholar|View at Indexing
Eckert LO, Jones CE, Kachikis A, Bardajà A, Da Silva FT, Absalon J, Rouse CE, Khalil A, Cutland CL, Kochhar S, Munoz FM. Obstetrics risk Assessment: Evaluation of selection criteria for vaccine research studies in pregnant women. Vaccine. 2020 Jun 15;38(29):4542-7. View at Publisher|View at Google Scholar|View at Indexing
Jin, Ze-Cheng, et al. "Genetic disruption of multiple α1, 2-mannosidases generates mammalian cells producing recombinant proteins with high-mannose–type N-glycans." Journal of Biological Chemistry 293.15 (2018): 5572-5584. View at Publisher|View at Google Scholar|View at Indexing
Luba Nalysnyk, M. D., Rebecca Sugarman, and Clifford Cele. "Budget Impact Analysis of Eliglustat for the Treatment of Gaucher Disease Type 1 in the United States." JOURNAL OF MANAGED (2018): 1002. View at Publisher|View at Google Scholar|View at Indexing
LEGHI, Gabriela Esteves, Fernanda Aparecida DOMENICI, and Helio VANNUCCHI. "Influência do estresse oxidativo e obesidade em pacientes com esteatohepatite não alcoólica." Arquivos de Gastroenterologia 52.3 (2015): 228-233. View at Publisher|View at Google Scholar|View at Indexing
Bastos, Luiza Lena, Miriam Ventura, and Elaine Reis Brandão. "Entre a biomedicina, a saúde pública e os direitos: um estudo sobre os argumentos do Consórcio Internacional sobre Contracepção de Emergência para promover o acesso aos contraceptivos de emergência em “países em desenvolvimento”." cadernos pagu (2018). View at Publisher|View at Google Scholar|View at Indexing
Iwamoto T, Taira N, Fujisawa T, Araki K, Sakamaki K, Sangai T, Kikawa Y, Shien T, Takao S, Sato M, Goto Y. Hormonal therapy resistant estrogen-receptor positive metastatic breast cancer cohort (HORSE-BC) study: current status of treatment selection in Japan. Acta Medica Okayama. 2018;72(4):369-74. View at Publisher|View at Google Scholar|View at Indexing
Logan JM, Brooks DA, Rowland A, Sorich MJ, Hopkins AM. Survival Outcomes of Nonsmall Cell Lung Cancer Patients Treated with Afatinib Who Are Affected by Early Adverse Events. Journal of Oncology. 2021 Jun 17;2021. View at Publisher|View at Google Scholar|View at Indexing
Penna ML, Buhrer-Sekula S, Pontes MA, Cruz R, Goncalves HD, Penna GO. Results from the clinical trial of uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): decrease in bacteriological index. Leprosy review. 2014 Dec 1;85(4):262-6. View at Publisher|View at Google Scholar|View at Indexing
Vaswani PA, Tropea TF, Dahodwala N. Overcoming barriers to Parkinson disease trial participation: increasing diversity and novel designs for recruitment and retention. Neurotherapeutics. 2020 Nov 4:1-2. View at Publisher|View at Google Scholar|View at Indexing
Wechsler, Michael E., et al. "SOURCE: a phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel group trial to evaluate the efficacy and safety of tezepelumab in reducing oral corticosteroid use in adults with oral corticosteroid dependent asthma." Respiratory Research 21.1 (2020): 1-10. View at Publisher|View at Google Scholar|View at Indexing
Nolan PM. Implicit Theory domains of Technology Ability and Health related to People with Parkinson's Engaging with a Speech Therapy Smartphone Application (Doctoral dissertation, University of Portsmouth). View at Publisher|View at Google Scholar|View at Indexing
Panettieri Jr, Reynold A., et al. "Tralokinumab for the treatment of severe, uncontrolled asthma: the ATMOSPHERE clinical development program." Immunotherapy 10.6 (2018): 473-490. View at Publisher|View at Google Scholar|View at Indexing
Berg D, Eggert K, Haslinger B, Kassubek J, Mollenhauer B, Reetz K, Rogge A, Schaeffer E, Tönges L, Zeuner KE. Disease modifying treatment trials in Parkinson’s disease: how to balance expectations and interests of patients, physicians and industry partners?. Neurological Research and Practice. 2020 Dec;2(1):1-3. View at Publisher|View at Google Scholar|View at Indexing
Hemken, Philip M., et al. "Development and analytical performance of a new ARCHITECT automated dipeptidyl peptidase-4 immunoassay." Practical laboratory medicine 9 (2017): 58-68. View at Publisher|View at Google Scholar|View at Indexing
Jain, Meena, et al. "Tralokinumab pharmacokinetics and tolerability when administered by different subcutaneous injection methods and rates." International journal of clinical pharmacology and therapeutics 55.7 (2017): 606. View at Publisher|View at Google Scholar|View at Indexing
Berg D, Eggert K, Haslinger B, Kassubek J, Mollenhauer B, Reetz K, Rogge A, Schaeffer E, Tönges L, Zeuner KE. Disease modifying treatment trials in Parkinson’s disease: how to balance expectations and interests of patients, physicians and industry partners?. Neurological Research and Practice. 2020 Dec;2(1):1-3. View at Publisher|View at Google Scholar|View at Indexing
Dubin, Celina, Ester Del Duca, and Emma Guttman-Yassky. "Drugs for the Treatment of Chronic Hand Eczema: Successes and Key Challenges." Therapeutics and Clinical Risk Management 16 (2020): 1319. View at Publisher|View at Google Scholar|View at Indexing
Khan, Tuba. "LEO Pharma Announces US Food and Drug Administration Fast Track Designation for delgocitinib Cream for the Treatment of Adults With Moderate-to-severe Chronic Hand Eczema." View at Publisher|View at Google Scholar|View at Indexing
Khan, Tuba. "LEO Pharma Announces US Food and Drug Administration Fast Track Designation for delgocitinib Cream for the Treatment of Adults With Moderate-to-severe Chronic Hand Eczema." View at Publisher|View at Google Scholar|View at Indexing
Lee, Ji Su, et al. "Efficacy and Safety of Oral Alitretinoin in Hand Eczema and Palmoplantar Pustulosis in Korean Patients." Annals of Dermatology 31.2 (2019): 139-145. View at Publisher|View at Google Scholar|View at Indexing